Methylphenidate Induced Lip and Tongue Biting
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Attention deficit hyperactivity disorder (ADHD) is a life-long neurodevelopmental disorder and treatment depends on pharmacotherapy because of its biological origin. Stimulant drugs are the most commonly used treatment for ADHD and they have various side effects. Herein, we report a case who bit off the tip of her tongue with Osmotic Release Oral System methylphenidate (OROS MPH) 36 mg/day, bit the tip of her lower lip with immediate release (IR) MPH 10 mg/day and lateral part of her tongue with IR MPH 20 mg/day. A diagnosis of epilepsy was unlikely because of the normal neurological examination and electroencephalography findings. This case was considered as an atypical side effect of MPH such as perseverative/compulsive behaviours and movement disorders. Clinicians should be aware of that stimulant medications may cause lip and tongue biting behavior and this may effect treatment compliance tremendously.
Abstract
Attention deficit hyperactivity disorder (ADHD) is a life-long neurodevelopmental disorder and treatment depends on pharmacotherapy because of its biological origin. Stimulant drugs are the most commonly used treatment for ADHD and they have various side effects. Herein, we report a case who bit off the tip of her tongue with Osmotic Release Oral System methylphenidate (OROS MPH) 36 mg/day, bit the tip of her lower lip with immediate release (IR) MPH 10 mg/day and lateral part of her tongue with IR MPH 20 mg/day. A diagnosis of epilepsy was unlikely because of the normal neurological examination and electroencephalography findings. This case was considered as an atypical side effect of MPH such as perseverative/compulsive behaviours and movement disorders. Clinicians should be aware of that stimulant medications may cause lip and tongue biting behavior and this may effect treatment compliance tremendously.
참고문헌 (8)
- Kessler RC, "Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication", Arch Gen Psychiatry, 62, pp.593~602 (2005)[DOI]
- Friedlander AH, "Dental management considerations in children with attention-deficit hyperactivity disorder", ASDC J Dent Child, 59, pp.196~201 (1992)
- 김붕년, "Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate- OROS (OROS-MPH): A Multi-center, Open-label Study in Korea", Clinical Psychopharmacology and Neuroscience, 9(1), pp.29~35 (2011), 대한정신약물학회
- Lowe TL, "Stimulant medications precipitate Tourette's syndrome", JAMA, 247, pp.1168~1169 (1982)[DOI]
- Koizumi HM, "Obsessive-compulsive symptoms following stimulants", Biol Psychiatry, 20, pp.1332~1333 (1985)[DOI]
- Serby M, "Methylphenidate-induced obsessive-compulsive symptoms in an elderly man", CNS Spectr, 8, pp.612~613 (2003)[DOI]
- Borcherding BG, "Motor", vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability?, 1990, pp.33, 83~94
- Beckman DA, "Developmental toxicity assessment of d,l-methylphenidate and d-methylphenidate in rats and rabbits", Birth Defects Res B Dev Reprod Toxicol, 83, pp.489~501 (2008)